MLN-4760 is a novel, potent and selective human angiotensin-converting (ACE2) inhibitor with IC50 of 0.44 nM and with excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypeptidase A (CPDA; IC50, 27 μM).

trans-4-Hydroxytamoxifen is an active metabolite of tamoxifen which is an ER antagonist and selective estrogen receptor modulator (SERM).

Lisinopril hydrate (MK-521), an enalapril analog, is a potent angiotensin-converting enzyme (ACE) inhibitor used in treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications of diabetes.

Trandolapril (RU-44570; Mavik; Gopten; RU44570; Odrik), an antihypertensive drug, is an oral and nonsulfhydryl prodrug that has to be hydrolysed to the active diacid Trandolaprilat.

Acetyl Tetrapeptide-5(also known as Eyeseryl), Inhibits skin glycosylation, reduces skin edema, removes dark circles and reduce bags under the eyes.

Olumacostat glasaretil (OG) is a novel and potent acetyl-CoA carboxylase inhibitor with anti-inflammatory effects.

Omapatrilat (also known as Vanlev; BMS-186716) is a novel investigational antihypertensive agent that acts as a potent dual inhibitor of the metalloproteases ACE (angiotensin converting enzyme) and NEP (neutral endopeptidase) with Ki values of 0.64 and 0.45 nM, respectively.

Ramiprilat, the active metabolite of Ramipril (HOE-498), is a novel and potent angiotensin-converting enzyme (ACE) inhibitor used as an antihypertensive drug.

Vicenin 2 is a novel and potent inhibitor of α-glucosidase, PTP1B, and RLAR.